William Blair & Company
AGL icon

William Blair & Company’s Agilon Health AGL Stock Holding History

William Blair & Company’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6,256
Closed -$360K – 1846
2025
Q2 		$360K Buy
6,256
+537
+9% +$43.1K ﹤0.01% 1193
2025
Q1 		$619K Sell
5,719
-4,471
-44% -$389K ﹤0.01% 1030
2024
Q4 		$484K Buy
10,190
+616
+6% +$37.2K ﹤0.01% 1104
2024
Q3 		$941K Buy
9,574
+332
+4% +$42.9K ﹤0.01% 921
2024
Q2 		$1.51M Sell
9,242
-441
-5% -$62.8K ﹤0.01% 759
2024
Q1 		$1.48M Buy
9,683
+744
+8% +$124K ﹤0.01% 763
2023
Q4 		$2.8M Sell
8,939
-3,925
-31% -$1.42M 0.01% 590
2023
Q3 		$5.71M Buy
12,864
+6,624
+106% +$2.99M 0.02% 410
2023
Q2 		$2.71M Buy
6,240
+661
+12% +$371K 0.01% 595
2023
Q1 		$3.31M Buy
5,579
+5,129
+1,140% +$2.87M 0.01% 537
2022
Q4 		$182K Buy
+450
New +$211K ﹤0.01% 1385
2021
Q3 		– Sell
-600
Closed -$609K – 1874
2021
Q2 		$609K Buy
+600
New +$526K ﹤0.01% 1085

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

William Blair & Company's AGL Position: Q3 2025 in Review

William Blair & Company sold out of Agilon Health (AGL) in Q3 2025, closing a stake of 6,256 shares — an estimated $360K sold.

William Blair & Company first reported a position in AGL in Q2 2021 and held it in 12 quarters. The position peaked at $5.71M in Q3 2023. 190 funds tracked by Wall St. Rank hold AGL as of Q3 2025.

  • William Blair & Company reported no remaining Agilon Health position as of Q3 2025 after selling out during the quarter.
  • William Blair & Company sold 6,256 Agilon Health shares in Q3 2025, an estimated $360K.
  • William Blair & Company first reported a position in Agilon Health in Q2 2021 and held it in 12 quarters.
  • William Blair & Company's Agilon Health position peaked at $5.71M in Q3 2023.
  • 190 funds tracked by Wall St. Rank held Agilon Health as of Q3 2025.

Based on William Blair & Company's 13F filing for Q3 2025, filed 12 Nov 2025.